Replies to post #129582 on Biotech Values

[mcbio]

A few other JAKs:

YMI CYT387 (JAK1/2) ph1/2 MF;
S*BIO ONX0803/SB1518 (JAK2) ph2 MF; ONX0805/SB1578 (JAK2) ph1;
SNY TG101348 (JAK2) ph1/2 MF;
AZN AZD1480 (JAK2) ph1 MF/solid tumor

Don't forget RIGL's JAK3 drug set to enter the clinic shortly in a transplant rejection setting, among others.